Blog

Roche vs. Natco – Genus vs. Species Patent Dispute over Risdiplam

Significant Shift in UPC Pharma Patent Litigation: Sanofi’s Recent Actions

FTC Backs Amneal on Unlawful Orange Book Listings

The opposite of “more”

November 2, 2020

Previous Page1 Page2 Next

ipEssentia is a boutique Intellectual Property firm with freshly brewed enthusiasm, empowered by decades of experience in building & leading the in-house Intellectual Property functions of multinational companies.

Important Links

About us
Contact Us
Disclaimer
Privacy Policy
Refund and Cancellation Policy
Shipping Policy
Terms and Conditions

Contact Us

Our Offices:
Noida, Hyderabad & Mumbai
INDIA
Call:
Dr. Poonam: +91 8008555339
Dr. Alka: +91 9820797387
info@ipessentia.com

Subscribe to our Newsletter

Design & Developed by Digicent

Scroll to Top

Blog

Roche vs. Natco – Genus vs. Species Patent Dispute over Risdiplam

Significant Shift in UPC Pharma Patent Litigation: Sanofi’s Recent Actions

FTC Backs Amneal on Unlawful Orange Book Listings

What’s your game?

The devil’s in the detail

A damp squib

Stand your Ground

Pay for Delay

Drain the swamp

Your job vs. your invention

Hop, hop, hop…..

The opposite of “more”